jimi

Article Details

Vol. 5 No. 2 (2026): Maret

Articles

Systematic Study of Multitarget Molecular Docking: from Polypharmacology to Tissue Pharmacology

S Saeful Amin R Regita Putri Cahyani A Anis Riyanti
13 March 2026 Vol. 5 No. 2 (2026): Maret https://doi.org/10.35912/jimi.v5i2.5697
Abstract

Purpose: This study describes the shift in modern drug discovery toward a computational systems-based paradigm, emphasizing multi-target molecular docking as a key strategy to unravel complex molecular interactions in biological systems.

Methods: A systematic literature review was conducted using publications from 2020 to 2025 retrieved from the PubMed, Scopus, ScienceDirect, and MDPI databases.

Results/findings: The analysis demonstrates that integrating molecular docking, Molecular Dynamics (MD) simulations, and network pharmacology enhances polypharmacology and drug repurposing strategies for complex diseases, such as diabetes, Alzheimer's, and viral infections. Bioactive compounds, including quercetin, luteolin, kaempferol, diosgenin, ?-amyrenone, and copper (II) complexes, target critical biological pathways (AGE–RAGE, NF-?B, STAT3–CASP3–HIF1A) and essential viral proteins.

Conclusions: The integration of multi-target molecular docking, network pharmacology, and AI-based drug design forms a new paradigm in modern drug discovery. This approach enables a systemic analysis of ligand–protein interactions, accelerates the identification of therapeutic targets, and improves the accuracy and efficiency of virtual screening. The combination of these three approaches strengthens the direction towards computational systems pharmacology, which supports data-driven and sustainable drug design.

Limitations: This study is based solely on existing computational data, without experimental validation to confirm the predicted interactions.

Contributions: This study highlights the integrative potential of multi-target molecular docking and network pharmacology as a bridge between computational prediction and experimental pharmacology. It offers a conceptual foundation for AI-assisted drug design and encourages future research on experimental validation and predictive modeling to optimize multitarget therapies.

Keywords: AI in Drug Discovery Drug Design Multi-target Molecular Docking Network Pharmacology Polypharmacology
How to Cite
“
Amin, S., Cahyani, R. P., & Riyanti, A. (2026). Systematic Study of Multitarget Molecular Docking: from Polypharmacology to Tissue Pharmacology. Jurnal Ilmu Medis Indonesia, 5(2), 21–33. https://doi.org/10.35912/jimi.v5i2.5697
Endnote/Zotero/Mendeley (RIS) BibTeX
References
  1. Abdelsayed, M. (2025). AI-driven polypharmacology in small-molecule drug discovery. International journal of molecular sciences, 26(14), 6996. doi:https://doi.org/10.3390/ijms26146996
  2. Ahmad, Z., & Amin, S. (2025). Literatur Penggunaan Molecular Docking Dalam Identifikasi Senyawa Potensial Sebagai Agen Anti-Sars-Cov-2. Journal of Public Health Science, 2(2), 230-238. doi:https://doi.org/10.70248/jophs.v2i2.2208
  3. Amin, S., Azijah, R. N., & Gunawan, F. R. (2025). Eksplorasi Senyawa Alami sebagai Lead Antikanker Payudara dengan Pendekatan In Silico. Jurnal Ilmu Medis Indonesia, 5(1), 63-74. doi:https://doi.org/10.35912/jimi.v5i1.4560
  4. Amin, S., Mustafidah, S., Nabila, N. S., & Maharani, C. (2025). Review Artikel: Pendekatan in Silico dalam Kimia Medisinal tentang Resistensi Antibiotik. Jurnal Ilmu Medis Indonesia, 5(1), 31-39. doi:https://doi.org/10.35912/jimi.v5i1.4561
  5. Amin, S., & Tsani, G. A. (2025). Tinjauan Literatur: Molecular Docking Fitokimia Indonesia Terhadap Target Terapeutik Empat Jenis Kanker. Journal of Public Health Science, 2(2), 183-190. doi:https://doi.org/10.70248/jophs.v2i2.2191
  6. Amin, S., Wihdatunnisa, I., Aisyah, R., & Kurniawan, Y. S. (2024). Potensi Senyawa Kuersetin sebagai Antikanker Payudara melalui Pendekatan Molecular Docking. Jurnal Ilmu Medis Indonesia, 4(1), 41-51. doi:https://doi.org/10.35912/jimi.v4i1.4565
  7. Arthi, P., Dharmasivam, M., Kaya, B., & Rahiman, A. K. (2023). Multi-target activity of copper complexes: Antibacterial, DNA binding, and molecular docking with SARS-CoV-2 receptor. Chemico-Biological Interactions, 373, 110349. doi:https://doi.org/10.1016/j.cbi.2023.110349
  8. Bi, X., Wang, Y., Wang, J., & Liu, C. (2025). Machine learning for multi-target drug discovery: Challenges and Opportunities in Systems Pharmacology. Pharmaceutics, 17(9), 1186. doi:https://doi.org/10.3390/pharmaceutics17091186
  9. Chakraborty, C., Bhattacharya, M., Lee, S.-S., Wen, Z.-H., & Lo, Y.-H. (2024). The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges. Molecular Therapy Nucleic Acids, 35(3), 1-21. doi:https://doi.org/10.1016/j.omtn.2024.102295
  10. Dong, Y., Tao, B., Xue, X., Feng, C., Ren, Y., Ma, H., Liu, S. (2021). Molecular mechanism of Epicedium treatment for depression based on network pharmacology and molecular docking technology. BMC Complementary Medicine and Therapies, 21(1), 222. doi:https://doi.org/10.1186/s12906-021-03389-w
  11. Doostmohammadi, A., Jooya, H., Ghorbanian, K., Gohari, S., & Dadashpour, M. (2024). Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents. Cell Communication and Signaling, 22(1), 228. doi:https://doi.org/10.1186/s12964-024-01607-9
  12. Guo, L., Li, J., Wang, C., Wei, J., Qin, Z., Teng, H., & Mei, X. (2025). Investigating the neuroprotective effects and the potential mechanisms of ?-amyrenone in cerebral ischemic/reperfusion injury based on pharmacology network, bioinformatics, and molecular docking simulation. Letters in Drug Design & Discovery, 22(8), 100135. doi:https://doi.org/10.1016/j.lddd.2025.100135
  13. Hidayah, N. A., & Amin, S. (2025). Tinjauan Literatur: Penggunaan Molecular Docking Dalam Identifikasi Senyawa Potensial Sebagai Agen Antidiabetes. Journal of Public Health Science, 2(2), 128-135. doi:https://doi.org/10.70248/jophs.v2i2.2231
  14. Hossain, M. S., & Hussain, M. H. (2025). Multi?Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations. Pharmacology Research & Perspectives, 13(4), e70131. doi:https://doi.org/10.1002/prp2.70131
  15. Kazemeini, S., Nadeem-Tariq, A., Shih, R., Rafanan, J., Ghani, N., & Vida, T. A. (2024). From plaques to pathways in Alzheimer’s disease: the mitochondrial-neurovascular-metabolic hypothesis. International Journal of Molecular Sciences, 25(21), 11720. doi:https://doi.org/10.3390/ijms252111720
  16. Kini, D. D., Dey, T., Theja, G. D., Shalini, S., Ruthicshaw, R., & SG, K. M. (2025). Multitarget Insights into Traditional Chinese Phytoconstituents against Tuberculosis via Network Pharmacology, Molecular Docking, and MD Simulation. Pharmacological Research-Modern Chinese Medicine, 17, 100695. doi:https://doi.org/10.1016/j.prmcm.2025.100695
  17. Luo, W., Deng, J., He, J., Yin, L., You, R., Zhang, L., He, J. (2023). Integration of molecular docking, molecular dynamics and network pharmacology to explore the multi?target pharmacology of fenugreek against diabetes. Journal of Cellular and Molecular Medicine, 27(14), 1959-1974. doi:https://doi.org/10.1111/jcmm.17787
  18. Meli, R., Morris, G. M., & Biggin, P. C. (2022). Scoring functions for protein-ligand binding affinity prediction using structure-based deep learning: a review. Frontiers in Bioinformatics, 2, 885983. doi:https://doi.org/10.3389/fbinf.2022.885983
  19. Mun, C. S., Hui, L. Y., Sing, L. C., Karunakaran, R., & Ravichandran, V. (2022). Multi-targeted molecular docking, pharmacokinetics, and drug-likeness evaluation of coumarin based compounds targeting proteins involved in development of COVID-19. Saudi Journal of Biological Sciences, 29(12), 103458. doi:https://doi.org/10.1016/j.sjbs.2022.103458
  20. Neelam, A. k. N. (2025). Advancing drug discovery: the role of computer-aided design and development in modern pharmaceuticals. Discover Pharmaceutical Sciences, 1(1), 8. doi:https://doi.org/10.1007/s44395-025-00008-2
  21. Qi, W., Shi, B., Tang, W., Zeng, J., Zhuo, M., & Ma, H. (2025). Integrating network pharmacology, molecular docking, and molecular dynamics simulations to explore potential compounds and mechanisms of Coptis Chinensis in Treating Streptococcal Infections. PeerJ, 13, e19960. doi:https://doi.org/10.7717/peerj.19960
  22. Reza, R., Dutta, T., Baildya, N., Ghosh, N. N., Khan, A. A., & Das, R. K. (2022). Repurposing of anti-lung cancer drugs as multi-target inhibitors of SARS-CoV-2 proteins: An insight from molecular docking and MD-simulation study. Microbial pathogenesis, 169, 105615. doi:https://doi.org/10.1016/j.micpath.2022.105615
  23. Syahputra, D., Ysrafil, Y., Alexandra, F. D., Praja, R. K., Fatmaria, F., & Pratika, R. A. (2024). Network pharmacology combined with molecular docking and molecular dynamics to verify the therapeutic potential of mung beans (Vigna radiata) against prostate cancer. Beni-Suef University Journal of Basic and Applied Sciences, 13(1), 100. doi:https://doi.org/10.1186/s43088-024-00552-3
  24. Syaqila, C. N., Pebralia, J., & Restianingsih, T. (2024). Molecular Docking Senyawa (8)-Shogaol Sebagai Obat Antikanker. Journal Online of Physics, 9(3), 72-76. doi:https://doi.org/10.22437/jop.v9i3.36116
  25. Tarkaa, C., Oyaniyi, D., Salaam, R., Ebuh, R., Akangbe, O., Oladokun, S., Ajayi, O. (2023). Elucidating the molecular targets of Curcuma longa for breast cancer treatment using network pharmacology, molecular docking, and molecular dynamics simulation. Precis. Med. Res, 5(2), 8. doi:https://doi.org/10.53388/pmr20230008
  26. Thapa, S., Maurya, S. N., Manjunath, K., Devi, K., Varghese, S. A., Lamsal, A., Biradar, M. S. (2025). LC-MS profiling and multi-target mechanistic insights of Hibiscus rosa-sinensis in diabetes: network pharmacology, molecular docking, MD simulation, PCA, and in-vitro ?-amylase inhibition. Pharmacological Research-Modern Chinese Medicine, 16, 100636. doi:https://doi.org/10.1016/j.prmcm.2025.100636
  27. Yang, G., Yao, P., Shang, S., Yang, J., Li, W., Chen, Y., & Zhang, H. (2025). The multi-target intervention reveals the mechanism by which Finerenone alleviates Polymyxin B-induced kidney injury: an integrated study of network pharmacology, transcriptomics, and molecular docking. European Journal of Pharmacology, 1005, 177968. doi:https://doi.org/10.1016/j.ejphar.2025.177968
  28. Zhai, Y., Liu, L., Zhang, F., Chen, X., Wang, H., Zhou, J., Lu, P. (2025). Network pharmacology: a crucial approach in traditional Chinese medicine research. Chinese Medicine, 20(1), 8. doi:https://doi.org/10.1186/s13020-024-01056-z
  29. Zhang, R., Zhu, X., Bai, H., & Ning, K. (2019). Network pharmacology databases for traditional Chinese medicine: review and assessment. Frontiers in Pharmacology, 10, 123. doi:https://doi.org/10.3389/fphar.2019.00123
License & Copyright
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Most read articles by the same author(s)